XMS Capital Partners, LLC is proud to serve as financial advisor to Exact Sciences in connection with the announced definitive agreement for Abbott to acquire Exact Sciences at an estimated enterprise value of $23 billion.

XMS Capital Partners LLC (“XMS”), a global, independent financial services firm focused on M&A, corporate advisory, and asset management services, is pleased to announce the addition of Richard (Rick) Kimball as a Managing Director. His appointment underscores XMS’s commitment to expanding its healthcare investment banking capabilities and delivering exceptional advisory services to clients.

XMS Capital Partners, LLC (“XMS”), a global, independent financial services firm focused on providing M&A, corporate advisory, capital raising and asset management services, is pleased to announce the addition of Paul Glover as Managing Director.

In Memoriam: Francis J. Oelerich III

XMS Capital Partners LLC (“XMS”), a global, independent financial services firm focused on providing M&A, corporate advisory and asset management services, is pleased to announce the expansion of its UK business with a focus on FinTech and Financial Services.

XMS Capital Partners LLC (“XMS”), a global, independent financial services firm focused on providing M&A, corporate advisory and asset management services, is pleased to announce the additions of Christopher Blake and Todd VanderMolen to the firm as Managing Directors.

XMS Capital Partners, LLC (“XMS”), a global, independent financial services firm focused on providing investment banking[…]

XMS Capital Partners Executive Director, Brian Brownschidle, served on the panel “A Look at Emerging Disruptors in Healthcare: Machine[…]

XMS Capital Executive Director, Brian Brownschidle was a panelist on the Revenue Cycle Management and Payor Services Investments panel […]

XMS Capital Partners, LLC (“XMS”), a global, independent financial services firm focused on providing investment banking, asset management and […]